With the assistance of our team, we are engaged in providing an extensive range of Eptifibatide Solution Injection to clients. It is hygienically processed by our team of medical experts. Eptifibatide Solution Injection is extensively used in hospitals for acute coronary syndrome and for patients undergoing PCI (percutaneous coronary intervention). Eptifibatide Solution Injection is antibiotic and has a balanced composition. Its temper-proof packaging keeps it safe for a long period.

Indications :

• Acute Coronary Syndrome
• Patients undergoing PCI (Percutaneous Coronary Intervention)

Dosage : Bolus dose followed by I.V Administration.
Renally Impaired Patients :

• Acute coronary syndrome : CrCl <50 mL/minute: Use 180mcg/kg bolus (max. : 22.6mg) & 1 mcg/kg/minute infusion (maximum : 7.5 mg/hour).

Percutaneous coronary intervention (PCI) with or without stenting :

• CrCl <50 mL/minute : Use 180 mcg/kg bolus (maximum: 22.6 mg) administered immediately before the initiation of PCI and followed by a continuous infusion of 1 mcg/kg/minute (maximum : 7.5 mg/hour). A second 180 mcg/kg (maximum : 22.6 mg) bolus should be administered 10 minutes after the first bolus. 

Packing : 75 mg/100 ml

With the assistance of our team, we are engaged in providing an extensive range of Eptifibatide Solution Injection to clients. It is hygienically processed by our team of medical experts. Eptifibatide Solution Injection is extensively used in hospitals for acute coronary syndrome and for patients undergoing PCI (percutaneous coronary intervention). Eptifibatide Solution Injection is antibiotic and has a balanced composition. Its temper-proof packaging keeps it safe for a long period.

Indications :

• Acute Coronary Syndrome
• Patients undergoing PCI (Percutaneous Coronary Intervention)

Dosage : Bolus dose followed by I.V Administration.
Renally Impaired Patients :

• Acute coronary syndrome : CrCl <50 mL/minute: Use 180mcg/kg bolus (max. : 22.6mg) & 1 mcg/kg/minute infusion (maximum : 7.5 mg/hour).

Percutaneous coronary intervention (PCI) with or without stenting :

• CrCl <50 mL/minute : Use 180 mcg/kg bolus (maximum: 22.6 mg) administered immediately before the initiation of PCI and followed by a continuous infusion of 1 mcg/kg/minute (maximum : 7.5 mg/hour). A second 180 mcg/kg (maximum : 22.6 mg) bolus should be administered 10 minutes after the first bolus. 

Packing : 75 mg/100 ml